Peptide payment processing and merchant accounts

Card scheme programmes such as the Visa Integrity Risk Program and Mastercard's Business Risk Assessment and Mitigation rules let the schemes fine acquirers for transactions involving unapproved drugs or misleading health claims. Several popular peptides are not approved medicines, and some appear on FDA lists of substances that compounding pharmacies may not use. Acquirers therefore need evidence that each merchant sells lawfully and markets accurately.

Prescription models sell compounded or approved peptides through licensed prescribers and pharmacies, usually with LegitScript or similar certification. Research supply models sell to laboratories and researchers with clear research-only terms. Acquirers treat these very differently, so state your model plainly. A store that mixes research-only labels with dosing guides, before and after photos or wellness claims is usually declined.

Acquirers that accept the sector typically want a registered company with transparent ownership, products sourced from identifiable manufacturers, third-party testing for each batch, and website copy with no claims to treat, cure or improve a condition. Prescription sellers need valid prescriber and pharmacy arrangements for every market they ship to. We do not work with sellers of products that require a prescription but are sold without one.

Prepare a certificate of analysis per batch from an independent laboratory, showing identity and purity testing such as HPLC and mass spectrometry, plus supplier invoices and a product list matched to those certificates. Underwriters may sample product pages against the documents, so the catalogue must match exactly.

Clear terms, refund and shipping policies, age and use acknowledgements at checkout, a recognisable billing descriptor and responsive customer support all reduce disputes. Remove reviews or affiliate content that make health claims, because acquirers judge the whole site, including user content and linked social channels.

Peptide merchants are usually placed with high-risk acquirers that accept nutraceutical or research supply categories, often with a rolling reserve for new accounts and lower initial limits. Many add ACH or bank transfer as a second payment rail so checkout continues during a processor review. Fees, reserves and limits are set by each acquirer after underwriting.

Expect company registration and ownership documents, ID for directors and beneficial owners, a business bank account, six months of processing statements if you have them, the testing file above, and a live website. Prescription models also need prescriber, pharmacy and certification evidence.

We review your products, sales model, website and processing history in a free consultation, flag gaps before an application, and point you toward acquirers whose appetite fits. We do not provide legal or regulatory sign-off, and approval and terms stay with the institution.